US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Takeda Pharmaceutical Co Ltd

18.67

+0.12500.67%

Volume:1.57M

Turnover:29.23M

Market Cap:58.97B

PE:83.06

High:18.72

Open:18.62

Low:18.56

Close:18.54

52wk High:18.79

52wk Low:12.99

Shares:3.16B

Float Shares:3.06B

Volume Ratio:0.74

T/O Rate:0.05%

Dividend:0.64

Dividend Rate:3.42%

EPS(TTM):0.2247

EPS(LYR):0.2245

ROE:1.50%

ROA:2.47%

PB:1.20

PE(LYR):83.15

Loading ...

Overview Company News Filings

Takeda Reports 47% of Patients Met Primary Endpoint in Entyvio Trial

Takeda announces data from Phase 3 KEPLER trial of ENTYVIO

Takeda’s New Stroke Trial Adds Long-Term Optionality to TAK’s Pipeline

Takeda’s HyQvia Study Tracks Real-World Use in Multiple Myeloma, Offering Gradual Upside for TAK Investors

Takeda Targets Better Hereditary Angioedema Diagnosis With New AHAE Study

Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live

Takeda Advances Phase 3 Teen Depression Trial, Underscoring Its Neuroscience Strategy

Takeda Pushes Pediatric Psoriasis Drug TAK-279 Forward With New Phase 3 Trial Update

Takeda Advances Oral Crohn’s Disease Drug TAK-279 With Active Mid-Stage Trial

Takeda granted Priority Review for oveporexton by FDA

Takeda Taps AI Startup Iambic In $1.7 Billion+ Deal To Speed Up Drug Discovery

Takeda Pharmaceutical Invests $1.7 Billion in Iambic to Expand AI-Powered Drug Discovery

Takeda’s TAK-188 Trial: Early Immunotherapy Bet in Advanced Solid Tumors

Takeda Advances TAK-360 Sleep Disorder Trial, Signaling Growing Ambition in Orexin-Based Therapies

Takeda Advances TAK-279 in Ulcerative Colitis: What Investors Should Watch Next

Takeda Flags Vyvanse Hit, Lifts 2025 Profit Guidance On Cost Control

Takeda raises FY25 core EPS view to 486 yen from 479 yen

Takeda reports Q3 core EPS 428 yen vs. 443 yen last year

Takeda Pharmaceutical Q3 Adj. EPS $0.47 Misses $0.55 Estimate, Sales $7.600B Miss $8.530B Estimate

Press Release: Takeda Reports Third-Quarter FY2025 Results: Updates Full Year Outlook to Reflect VYVANSE(R) Generics Impact, OPEX Discipline and FX Tailwind; Progressing Toward Three Transformative Launches Ahead

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TAK/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TAK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","market":"US","secType":"STK","nameCN":"Takeda Pharmaceutical Co Ltd","latestPrice":18.665,"timestamp":1771529129201,"preClose":18.54,"halted":0,"volume":1569996,"delay":0,"changeRate":0.00674217907227616,"floatShares":3057000000,"shares":3159188548,"eps":0.224727,"marketStatus":"Trading","change":0.125,"latestTime":"02-19 14:25:37 EST","open":18.615,"high":18.72,"low":18.56,"amount":29232673.97166,"amplitude":0.00863,"askPrice":18.67,"askSize":1852,"bidPrice":18.66,"bidSize":1400,"shortable":3,"etf":0,"ttmEps":0.224727,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771534800000},"marketStatusCode":2,"adr":0,"adrRate":0.5,"listingDate":1545627600000,"exchange":"NYSE","adjPreClose":18.54,"dividendRate":0.034556,"preHourTrading":{"tag":"盘前","latestPrice":18.59,"preClose":18.54,"latestTime":"09:13 EST","volume":24528,"amount":458093.56185600004,"timestamp":1771510427752,"change":0.05,"changeRate":0.002697,"amplitude":0.012945},"postHourTrading":{"tag":"盘后","latestPrice":18.6,"preClose":18.54,"latestTime":"19:00 EST","volume":1793,"amount":33389.2404,"timestamp":1771459243161,"change":0.06,"changeRate":0.003236,"amplitude":0.014461},"volumeRatio":0.739261,"impliedVol":0.0721,"impliedVolPercentile":0.004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","floatShares":3057000000,"roa":"2.47%","roe":"1.50%","lyrEps":0.224477,"volumeRatio":0.739261,"shares":3159188548,"dividePrice":0.639045,"high":18.72,"amplitude":0.00863,"preClose":18.54,"low":18.56,"week52Low":12.99,"pbRate":"1.20","psRate":"2.05","week52High":18.788,"institutionHeld":0.1079,"latestPrice":18.665,"committee":-0.138991,"eps":0.224727,"divideRate":0.034238,"volume":1569996,"delay":0,"ttmEps":0.224727,"open":18.615,"prevYearClose":15.59,"prevWeekClose":18.46,"prevMonthClose":17.23,"prevQuarterClose":15.59,"fiveDayClose":18.28,"twentyDayClose":16.08,"sixtyDayClose":14.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TAK\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-01-29","symbol":"TAK","fiscalQuarterEnding":"2025/12","expectedEps":0.55,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1769662800000,"reportTimeType":"pre","actualEps":0.48},{"date":"2025-10-30","symbol":"TAK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":0.44,"defaultRemindTime":1761811200000,"name":null,"time":"Pre-Market","dateTimestamp":1761796800000,"actualEps":0.44},{"market":"US","date":"2025-07-30","symbol":"TAK","fiscalQuarterEnding":"2025/06","expectedEps":0.47,"name":null,"time":"","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"","actualEps":0.52},{"market":"US","date":"2025-01-30","symbol":"TAK","fiscalQuarterEnding":"2024/12","expectedEps":0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738213200000,"reportTimeType":"pre","actualEps":0.42},{"market":"US","date":"2024-10-31","symbol":"TAK","fiscalQuarterEnding":"2024/09","expectedEps":0.39,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":0.44}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TAK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TAK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1689570000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TAK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TAK","date":"2026-02-18","current":82.5001,"percent":0.9512,"low":9.919003,"twenty":15.819699,"median":29.842804,"eighty":45.284184,"high":247.195474,"avg":39.678952,"sd":43.626601,"marketCap":59441180233.72},"quantilePoints":[{"date":"2021-02-19","current":31.997411,"twenty":30.238705,"median":43.337626,"eighty":92.438506,"marketCap":54757645997.71},{"date":"2021-02-26","current":31.00209,"twenty":30.269781,"median":42.961129,"eighty":92.297171,"marketCap":52506642547.95},{"date":"2021-03-05","current":32.525364,"twenty":30.307584,"median":42.874245,"eighty":92.272802,"marketCap":54273339139.55},{"date":"2021-03-12","current":34.741035,"twenty":30.314105,"median":42.671516,"eighty":92.258181,"marketCap":57572160306.5},{"date":"2021-03-19","current":36.991326,"twenty":30.320622,"median":42.376112,"eighty":92.258181,"marketCap":61377881020.81},{"date":"2021-03-26","current":36.385479,"twenty":30.34278,"median":42.069006,"eighty":92.219192,"marketCap":59972674222.12},{"date":"2021-04-01","current":35.38287,"twenty":30.371454,"median":41.476727,"eighty":92.150961,"marketCap":57783874962.89},{"date":"2021-04-09","current":32.481215,"twenty":30.393667,"median":38.431569,"eighty":92.111972,"marketCap":53478879478.89},{"date":"2021-04-16","current":32.082779,"twenty":30.470959,"median":38.377853,"eighty":92.111972,"marketCap":53250001858.4},{"date":"2021-04-23","current":31.900884,"twenty":30.513064,"median":38.294386,"eighty":92.058362,"marketCap":53341682665.94},{"date":"2021-04-30","current":31.485125,"twenty":30.533079,"median":38.21414,"eighty":91.833434,"marketCap":52029509066.16},{"date":"2021-05-07","current":31.831591,"twenty":30.534382,"median":38.169603,"eighty":91.791488,"marketCap":52970833572.63},{"date":"2021-05-14","current":15.564762,"twenty":30.470959,"median":38.145677,"eighty":91.758112,"marketCap":53496176267.97},{"date":"2021-05-21","current":15.876889,"twenty":30.319318,"median":38.091991,"eighty":91.609986,"marketCap":54795356598.76},{"date":"2021-05-28","current":15.664642,"twenty":30.236167,"median":38.041392,"eighty":91.546628,"marketCap":53587690959.61},{"date":"2021-06-04","current":15.281766,"twenty":30.057838,"median":37.818162,"eighty":91.527134,"marketCap":52499044333.6},{"date":"2021-06-11","current":15.732274,"twenty":29.940017,"median":37.70687,"eighty":91.283451,"marketCap":53886220157.49},{"date":"2021-06-18","current":15.499142,"twenty":29.705398,"median":37.644832,"eighty":91.259083,"marketCap":52855138856.99},{"date":"2021-06-25","current":15.64495,"twenty":29.653254,"median":37.496711,"eighty":91.185978,"marketCap":53110087882.29},{"date":"2021-07-02","current":15.624135,"twenty":29.556114,"median":37.309512,"eighty":90.966664,"marketCap":52790633079.89},{"date":"2021-07-09","current":15.170356,"twenty":29.369182,"median":37.239049,"eighty":90.713234,"marketCap":51765371608.86},{"date":"2021-07-16","current":15.553362,"twenty":29.036801,"median":37.034171,"eighty":90.649877,"marketCap":53089153550.44},{"date":"2021-07-23","current":15.445121,"twenty":28.610503,"median":36.990446,"eighty":90.630383,"marketCap":52540828243.5},{"date":"2021-07-30","current":13.400212,"twenty":26.987384,"median":36.968687,"eighty":90.397999,"marketCap":52641482781.37},{"date":"2021-08-06","current":13.231512,"twenty":25.788836,"median":36.881192,"eighty":90.295707,"marketCap":51739766156.6},{"date":"2021-08-13","current":13.399277,"twenty":25.542527,"median":36.851251,"eighty":90.284353,"marketCap":52624385513.69},{"date":"2021-08-20","current":13.340924,"twenty":25.375364,"median":36.822486,"eighty":90.167386,"marketCap":52391869685.63},{"date":"2021-08-27","current":13.304453,"twenty":25.07978,"median":36.81694,"eighty":90.040671,"marketCap":52184954198.97},{"date":"2021-09-03","current":13.585277,"twenty":24.895379,"median":36.800541,"eighty":89.938325,"marketCap":53414238064.1},{"date":"2021-09-10","current":13.6801,"twenty":24.732641,"median":36.787118,"eighty":89.91883,"marketCap":53684261064.92},{"date":"2021-09-17","current":13.906217,"twenty":24.583535,"median":36.72461,"eighty":89.874967,"marketCap":54565644835.19},{"date":"2021-09-24","current":13.753041,"twenty":24.444102,"median":36.66065,"eighty":89.831104,"marketCap":53563443001.25},{"date":"2021-10-01","current":13.260689,"twenty":24.187434,"median":36.617455,"eighty":89.777494,"marketCap":51482210756.95},{"date":"2021-10-08","current":11.666926,"twenty":23.93319,"median":36.601121,"eighty":89.748252,"marketCap":44862900501.13},{"date":"2021-10-15","current":11.787279,"twenty":23.7033,"median":36.578836,"eighty":89.499696,"marketCap":44516597060.99},{"date":"2021-10-22","current":11.681514,"twenty":23.539863,"median":36.5454,"eighty":88.968468,"marketCap":44293684279.19},{"date":"2021-10-29","current":10.648321,"twenty":23.423498,"median":36.488155,"eighty":88.710165,"marketCap":44164269191.12},{"date":"2021-11-05","current":10.784625,"twenty":23.226892,"median":36.468627,"eighty":88.627312,"marketCap":44983557825.66},{"date":"2021-11-12","current":10.950849,"twenty":22.951173,"median":36.398869,"eighty":88.490851,"marketCap":45493195113.2},{"date":"2021-11-19","current":10.728109,"twenty":22.593579,"median":36.365388,"eighty":88.33002,"marketCap":44596449686.83},{"date":"2021-11-26","current":10.425581,"twenty":22.055183,"median":36.25968,"eighty":88.252042,"marketCap":43512424769.26},{"date":"2021-12-03","current":10.106651,"twenty":21.515452,"median":36.172679,"eighty":88.178937,"marketCap":42286529642.36},{"date":"2021-12-10","current":10.142864,"twenty":21.321368,"median":36.088488,"eighty":87.847529,"marketCap":42348534488.31},{"date":"2021-12-17","current":10.34424,"twenty":21.015505,"median":36.02197,"eighty":87.423521,"marketCap":43082485607.36},{"date":"2021-12-23","current":10.363994,"twenty":20.795645,"median":35.82744,"eighty":87.174965,"marketCap":42874132957.12},{"date":"2021-12-31","current":10.327779,"twenty":20.657578,"median":35.632629,"eighty":86.517022,"marketCap":42437110052.52},{"date":"2022-01-07","current":10.522022,"twenty":20.640925,"median":35.562823,"eighty":86.434171,"marketCap":43033429977.32},{"date":"2022-01-14","current":11.009273,"twenty":20.536864,"median":35.556871,"eighty":86.322076,"marketCap":45750368973.66},{"date":"2022-01-21","current":10.940136,"twenty":20.171308,"median":35.520843,"eighty":86.263593,"marketCap":45488233052.08},{"date":"2022-01-28","current":10.953305,"twenty":19.949589,"median":35.455688,"eighty":85.922437,"marketCap":44994125510.56},{"date":"2022-02-04","current":12.019761,"twenty":19.86233,"median":35.393845,"eighty":85.355005,"marketCap":45736794370.02},{"date":"2022-02-11","current":12.502153,"twenty":19.831282,"median":35.308236,"eighty":85.302091,"marketCap":47298200126.65},{"date":"2022-02-18","current":12.558981,"twenty":19.671006,"median":35.308236,"eighty":85.302091,"marketCap":47834673171.52},{"date":"2022-02-25","current":12.196703,"twenty":19.550551,"median":35.308236,"eighty":85.302091,"marketCap":46263555485.74},{"date":"2022-03-04","current":12.289048,"twenty":19.380891,"median":35.308236,"eighty":85.302091,"marketCap":46976698663.99},{"date":"2022-03-11","current":12.043978,"twenty":19.117196,"median":35.308236,"eighty":85.302091,"marketCap":45095629553.81},{"date":"2022-03-18","current":12.707196,"twenty":18.980245,"median":35.308236,"eighty":85.302091,"marketCap":46769031069.82},{"date":"2022-03-25","current":12.770838,"twenty":18.858799,"median":35.308236,"eighty":85.302091,"marketCap":45895036970.15},{"date":"2022-04-01","current":12.530413,"twenty":18.69121,"median":35.308236,"eighty":85.302091,"marketCap":44742437445.66},{"date":"2022-04-08","current":13.064299,"twenty":18.623126,"median":35.308236,"eighty":85.302091,"marketCap":46073289723.14},{"date":"2022-04-14","current":13.294114,"twenty":18.443795,"median":35.308236,"eighty":85.302091,"marketCap":46294767383.12},{"date":"2022-04-22","current":13.21633,"twenty":18.221438,"median":35.308236,"eighty":85.302091,"marketCap":45025239824.55},{"date":"2022-04-29","current":13.325935,"twenty":17.979017,"median":35.308236,"eighty":85.302091,"marketCap":45022632781.95},{"date":"2022-05-06","current":13.53454,"twenty":17.700642,"median":35.308236,"eighty":85.302091,"marketCap":45566277364},{"date":"2022-05-13","current":24.629857,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":43848144051.53},{"date":"2022-05-20","current":25.018997,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45016426783.75},{"date":"2022-05-27","current":25.119636,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45470626890.48},{"date":"2022-06-03","current":24.280973,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":42728413394.89},{"date":"2022-06-10","current":24.368194,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":41777808638.38},{"date":"2022-06-17","current":23.83145,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":40560767412.66},{"date":"2022-06-24","current":24.871564,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42352646298.73},{"date":"2022-07-01","current":25.220478,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42911856821.29},{"date":"2022-07-08","current":26.059148,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44046297256.04},{"date":"2022-07-15","current":26.763631,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44459950529.79},{"date":"2022-07-22","current":26.817305,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45321441244.41},{"date":"2022-07-29","current":30.743571,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45477961048.28},{"date":"2022-08-05","current":29.247514,"twenty":15.868566,"median":35.251678,"eighty":85.31532,"marketCap":42639852719.36},{"date":"2022-08-12","current":29.748811,"twenty":15.868566,"median":35.071486,"eighty":85.31532,"marketCap":43951767417.68},{"date":"2022-08-19","current":29.8898,"twenty":15.868566,"median":34.741035,"eighty":85.31532,"marketCap":43038704613},{"date":"2022-08-26","current":29.874135,"twenty":15.868566,"median":33.797644,"eighty":85.31532,"marketCap":42969756201.7},{"date":"2022-09-02","current":30.022957,"twenty":15.868566,"median":32.525364,"eighty":85.31532,"marketCap":42304023842.38},{"date":"2022-09-09","current":30.65741,"twenty":15.868566,"median":32.307982,"eighty":85.31532,"marketCap":42457872052.31},{"date":"2022-09-16","current":30.406762,"twenty":15.868566,"median":32.13589,"eighty":85.31532,"marketCap":41975860478.2},{"date":"2022-09-23","current":29.784868,"twenty":15.868566,"median":32.082779,"eighty":85.31532,"marketCap":41053322910.74},{"date":"2022-09-30","current":29.611929,"twenty":15.868566,"median":31.991351,"eighty":85.31532,"marketCap":40398024705.55},{"date":"2022-10-07","current":29.784868,"twenty":15.868566,"median":31.910861,"eighty":85.31532,"marketCap":40490115913.28},{"date":"2022-10-14","current":30.091442,"twenty":15.868566,"median":31.822929,"eighty":85.31532,"marketCap":40007811364.69},{"date":"2022-10-21","current":29.234607,"twenty":15.868566,"median":31.680102,"eighty":85.31532,"marketCap":38943108088.84},{"date":"2022-10-28","current":27.96678,"twenty":15.868566,"median":31.562866,"eighty":85.31532,"marketCap":40412932074.34},{"date":"2022-11-04","current":27.990228,"twenty":15.868566,"median":31.51076,"eighty":85.31532,"marketCap":40544936411.09},{"date":"2022-11-11","current":28.209015,"twenty":15.868566,"median":31.374814,"eighty":85.31532,"marketCap":43206259311.05},{"date":"2022-11-18","current":28.704934,"twenty":15.868566,"median":31.254645,"eighty":85.31532,"marketCap":43730486647.27},{"date":"2022-11-25","current":29.426933,"twenty":15.868566,"median":31.201154,"eighty":85.31532,"marketCap":45057111010.77},{"date":"2022-12-02","current":28.931014,"twenty":15.868566,"median":31.037761,"eighty":85.31532,"marketCap":45570767384.44},{"date":"2022-12-09","current":29.835336,"twenty":15.868566,"median":30.937343,"eighty":85.31532,"marketCap":46637499358.3},{"date":"2022-12-16","current":30.331255,"twenty":15.868566,"median":30.871973,"eighty":85.31532,"marketCap":47313819017.43},{"date":"2022-12-23","current":29.900973,"twenty":15.868566,"median":30.772934,"eighty":85.31532,"marketCap":47996239753.01},{"date":"2022-12-30","current":29.981195,"twenty":15.868566,"median":30.71556,"eighty":85.31532,"marketCap":48463304453.77},{"date":"2023-01-06","current":29.755114,"twenty":15.868566,"median":30.572454,"eighty":85.31532,"marketCap":47870974965.36},{"date":"2023-01-13","current":29.864508,"twenty":15.868566,"median":30.484406,"eighty":85.31532,"marketCap":49882681588.13},{"date":"2023-01-20","current":30.426063,"twenty":15.868566,"median":30.426063,"eighty":85.31532,"marketCap":49943652563.58},{"date":"2023-01-27","current":30.148932,"twenty":15.868566,"median":30.406762,"eighty":85.31532,"marketCap":49467797966.47},{"date":"2023-02-03","current":23.618692,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49524315647.28},{"date":"2023-02-10","current":23.884908,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49885153889.85},{"date":"2023-02-17","current":23.681054,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48373362782.36},{"date":"2023-02-24","current":23.799969,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":47942402215.74},{"date":"2023-03-03","current":24.043461,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48450666632.88},{"date":"2023-03-10","current":24.621048,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50074775527.78},{"date":"2023-03-17","current":24.802252,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51520828536.51},{"date":"2023-03-24","current":24.139732,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50698940566.02},{"date":"2023-03-31","current":24.63238,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":50868882296.85},{"date":"2023-04-06","current":24.898523,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":51908951328.51},{"date":"2023-04-14","current":25.289243,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52430478946.56},{"date":"2023-04-21","current":25.436471,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52090554629.18},{"date":"2023-04-28","current":25.549723,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52360758781.69},{"date":"2023-05-05","current":25.934781,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":53114594501.1},{"date":"2023-05-12","current":21.816188,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51463307525.88},{"date":"2023-05-19","current":21.919152,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50148262100.11},{"date":"2023-05-26","current":22.174322,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50264110513.18},{"date":"2023-06-02","current":21.909524,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50016322403.86},{"date":"2023-06-09","current":22.247876,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50740318667.02},{"date":"2023-06-16","current":22.419504,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50575421543.16},{"date":"2023-06-23","current":22.547244,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":50034367985.85},{"date":"2023-06-30","current":22.199081,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48652831553.96},{"date":"2023-07-07","current":21.625347,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47542321682.04},{"date":"2023-07-14","current":21.105555,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48436114801.39},{"date":"2023-07-21","current":21.512562,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48597606707.51},{"date":"2023-07-28","current":22.302484,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47655983749.28},{"date":"2023-08-04","current":22.405905,"twenty":15.864404,"median":30.349157,"eighty":85.328548,"marketCap":47472091400.73},{"date":"2023-08-11","current":22.962958,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47925971293.26},{"date":"2023-08-18","current":22.653484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":46744998549.67},{"date":"2023-08-25","current":22.947484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47472892956.93},{"date":"2023-09-01","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":48142626644.03},{"date":"2023-09-08","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":47619131084.19},{"date":"2023-09-15","current":25.06738,"twenty":15.864404,"median":30.239629,"eighty":85.328548,"marketCap":51339735089.9},{"date":"2023-09-22","current":24.298853,"twenty":15.864404,"median":30.152523,"eighty":85.328548,"marketCap":49671905160.78},{"date":"2023-09-29","current":23.9378,"twenty":15.864404,"median":30.101284,"eighty":85.328548,"marketCap":48306094881.06},{"date":"2023-10-06","current":23.12801,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":46912236069.61},{"date":"2023-10-13","current":23.4478,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":47185225879.19},{"date":"2023-10-20","current":22.447168,"twenty":15.864404,"median":30.035164,"eighty":85.328548,"marketCap":45133632614.81},{"date":"2023-10-27","current":33.018744,"twenty":15.848805,"median":30.061417,"eighty":85.468491,"marketCap":42045438777.36},{"date":"2023-11-03","current":33.977052,"twenty":15.848805,"median":30.109117,"eighty":85.468491,"marketCap":43262280273.82},{"date":"2023-11-10","current":34.001614,"twenty":15.848805,"median":30.156114,"eighty":85.468491,"marketCap":43146195810.29},{"date":"2023-11-17","current":34.509223,"twenty":15.848805,"median":30.265619,"eighty":85.468491,"marketCap":43924997173.45},{"date":"2023-11-24","current":34.411351,"twenty":15.848805,"median":30.338548,"eighty":85.468491,"marketCap":44071202551.42},{"date":"2023-12-01","current":34.149357,"twenty":15.848805,"median":30.406762,"eighty":85.468491,"marketCap":44271809028.5},{"date":"2023-12-08","current":33.224188,"twenty":15.856081,"median":30.46982,"eighty":85.355005,"marketCap":44164475676.92},{"date":"2023-12-15","current":32.708387,"twenty":15.856081,"median":30.676992,"eighty":85.355005,"marketCap":44261463171.18},{"date":"2023-12-22","current":32.732997,"twenty":15.856081,"median":31.207345,"eighty":85.355005,"marketCap":44132705649.12},{"date":"2023-12-29","current":33.191488,"twenty":15.848805,"median":31.270394,"eighty":85.468491,"marketCap":45078827041.22},{"date":"2024-01-05","current":35.107326,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46553386498.52},{"date":"2024-01-12","current":35.467569,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46529118760.4},{"date":"2024-01-19","current":35.574004,"twenty":15.834252,"median":31.485125,"eighty":85.695464,"marketCap":46054562134.98},{"date":"2024-01-26","current":35.287452,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45813893702.51},{"date":"2024-02-02","current":37.669312,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45919514328.61},{"date":"2024-02-09","current":37.493246,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":44733412617.38},{"date":"2024-02-16","current":38.84015,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46075141205.13},{"date":"2024-02-23","current":39.033823,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46211688108.13},{"date":"2024-03-01","current":38.637675,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45954550562.52},{"date":"2024-03-08","current":38.311953,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":46140815426.08},{"date":"2024-03-15","current":37.871788,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45561442683.96},{"date":"2024-03-22","current":38.796134,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45585981704.56},{"date":"2024-03-28","current":37.000261,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":43584427473.65},{"date":"2024-04-05","current":36.269795,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42616375994.67},{"date":"2024-04-12","current":36.498683,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42430179712.64},{"date":"2024-04-19","current":35.820825,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41294416133.79},{"date":"2024-04-26","current":35.997119,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41249770241.05},{"date":"2024-05-03","current":36.314041,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42076379836.26},{"date":"2024-05-10","current":36.349255,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41627594417.07},{"date":"2024-05-17","current":44.976968,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41733682877.63},{"date":"2024-05-24","current":45.020529,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41285104836.56},{"date":"2024-05-31","current":45.445251,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41644103120.04},{"date":"2024-06-07","current":46.087779,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42404430023},{"date":"2024-06-14","current":45.107651,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41300590483.72},{"date":"2024-06-21","current":43.866156,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":39610552206.76},{"date":"2024-06-28","current":45.436656,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":40691773038.88},{"date":"2024-07-05","current":46.209907,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41429859502.63},{"date":"2024-07-12","current":47.281654,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43144411716.7},{"date":"2024-07-19","current":46.533596,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42599959119.02},{"date":"2024-07-26","current":46.698609,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43774096625.98},{"date":"2024-08-02","current":44.272889,"twenty":15.841528,"median":31.485125,"eighty":84.95809,"marketCap":45300242074.37},{"date":"2024-08-09","current":43.014896,"twenty":15.841528,"median":31.485125,"eighty":84.034079,"marketCap":44025677518.59},{"date":"2024-08-16","current":45.710595,"twenty":15.841528,"median":31.485125,"eighty":83.611233,"marketCap":46246726032.37},{"date":"2024-08-23","current":46.418876,"twenty":15.841528,"median":31.485125,"eighty":83.285679,"marketCap":48080793858.92},{"date":"2024-08-30","current":45.805737,"twenty":15.841528,"median":31.485125,"eighty":82.840382,"marketCap":47110126928.06},{"date":"2024-09-06","current":45.150312,"twenty":15.841528,"median":31.485125,"eighty":82.567216,"marketCap":47633333133.33},{"date":"2024-09-13","current":43.733749,"twenty":15.841528,"median":31.485125,"eighty":82.35018,"marketCap":46692187320.02},{"date":"2024-09-20","current":45.192598,"twenty":15.841528,"median":31.485125,"eighty":81.917164,"marketCap":46914983400.73},{"date":"2024-09-27","current":44.008604,"twenty":15.841528,"median":31.485125,"eighty":81.717782,"marketCap":46173769906.47},{"date":"2024-10-04","current":44.8226,"twenty":15.841528,"median":31.485125,"eighty":81.193902,"marketCap":45207064894.75},{"date":"2024-10-11","current":45.034027,"twenty":15.841528,"median":31.485125,"eighty":80.903118,"marketCap":45273197191.14},{"date":"2024-10-18","current":45.203169,"twenty":15.841528,"median":31.485125,"eighty":80.121066,"marketCap":45314702691.87},{"date":"2024-10-25","current":43.395465,"twenty":15.841528,"median":31.485125,"eighty":79.259288,"marketCap":42802477236.79},{"date":"2024-11-01","current":23.34074,"twenty":15.841528,"median":31.394177,"eighty":76.252009,"marketCap":44255337707.7},{"date":"2024-11-08","current":23.061963,"twenty":15.841528,"median":31.223737,"eighty":52.659045,"marketCap":43818726338.15},{"date":"2024-11-15","current":23.302476,"twenty":15.841528,"median":30.720073,"eighty":52.113395,"marketCap":43649113935.95},{"date":"2024-11-22","current":22.482544,"twenty":15.841528,"median":30.492581,"eighty":51.914978,"marketCap":42094765685.01},{"date":"2024-11-29","current":22.318557,"twenty":15.841528,"median":30.428162,"eighty":51.719171,"marketCap":43004121919.03},{"date":"2024-12-06","current":22.537206,"twenty":15.841528,"median":30.363743,"eighty":51.54686,"marketCap":43593417925.5},{"date":"2024-12-13","current":22.602801,"twenty":15.841528,"median":30.265696,"eighty":51.06387,"marketCap":42654808427.14},{"date":"2024-12-20","current":22.438814,"twenty":15.841528,"median":30.156169,"eighty":50.729692,"marketCap":41620825476.96},{"date":"2024-12-27","current":22.89251,"twenty":15.841528,"median":30.11976,"eighty":50.270198,"marketCap":42157933916.75},{"date":"2025-01-03","current":22.854246,"twenty":15.841528,"median":30.084614,"eighty":49.695831,"marketCap":42120101324.52},{"date":"2025-01-10","current":22.526274,"twenty":15.834252,"median":30.039538,"eighty":48.706353,"marketCap":41387819255.78},{"date":"2025-01-17","current":22.072578,"twenty":15.834252,"median":29.98139,"eighty":47.742982,"marketCap":40954868347.09},{"date":"2025-01-24","current":22.056179,"twenty":15.834252,"median":29.928964,"eighty":47.376261,"marketCap":41086375616.12},{"date":"2025-01-31","current":32.066996,"twenty":15.834252,"median":29.8898,"eighty":47.184847,"marketCap":43068627249.87},{"date":"2025-02-07","current":31.518451,"twenty":15.834252,"median":29.8898,"eighty":46.698609,"marketCap":43370831342.3},{"date":"2025-02-14","current":31.625402,"twenty":15.834252,"median":29.8898,"eighty":46.623803,"marketCap":43271885610.15},{"date":"2025-02-21","current":32.135858,"twenty":15.834252,"median":29.8898,"eighty":46.463276,"marketCap":44737299221.36},{"date":"2025-02-28","current":33.019632,"twenty":15.834252,"median":29.8898,"eighty":46.1861,"marketCap":45710719655.87},{"date":"2025-03-07","current":33.965435,"twenty":15.826975,"median":29.881968,"eighty":45.994515,"marketCap":47968574450.17},{"date":"2025-03-14","current":32.579894,"twenty":15.826975,"median":29.881968,"eighty":45.856479,"marketCap":45709305301.84},{"date":"2025-03-21","current":33.462021,"twenty":15.826975,"median":29.881968,"eighty":45.756962,"marketCap":46697220950.86},{"date":"2025-03-28","current":32.837181,"twenty":15.826975,"median":29.881968,"eighty":45.646342,"marketCap":45537525126.69},{"date":"2025-04-04","current":32.910692,"twenty":15.826975,"median":29.881968,"eighty":45.486482,"marketCap":46959977925.4},{"date":"2025-04-11","current":28.911716,"twenty":15.834252,"median":29.864508,"eighty":45.423604,"marketCap":41903036554.51},{"date":"2025-04-17","current":30.516053,"twenty":15.834252,"median":29.864508,"eighty":45.37687,"marketCap":44665727413.14},{"date":"2025-04-25","current":31.299454,"twenty":15.826975,"median":29.853656,"eighty":45.205165,"marketCap":45236702475.67},{"date":"2025-05-02","current":32.353752,"twenty":15.826975,"median":29.853656,"eighty":45.143969,"marketCap":46627023849.03},{"date":"2025-05-09","current":62.186826,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46246122430},{"date":"2025-05-16","current":59.013194,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":43629573670.78},{"date":"2025-05-23","current":60.272181,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":45243750600.82},{"date":"2025-05-30","current":62.428377,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46713186360.41},{"date":"2025-06-06","current":62.153426,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46690667816.43},{"date":"2025-06-13","current":62.934861,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":47259274399.65},{"date":"2025-06-20","current":62.052124,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45950911927.98},{"date":"2025-06-27","current":63.18087,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47191840400.65},{"date":"2025-07-03","current":64.005724,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47693415916.83},{"date":"2025-07-11","current":64.055104,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47209686047.66},{"date":"2025-07-18","current":63.513752,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46158538139.51},{"date":"2025-07-25","current":63.308916,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46555456308.17},{"date":"2025-08-01","current":48.106805,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43759985637.51},{"date":"2025-08-08","current":48.654381,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45191185373.67},{"date":"2025-08-15","current":50.297108,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46622420863.67},{"date":"2025-08-22","current":52.350517,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":48379407617.45},{"date":"2025-08-29","current":50.434002,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46969989485.26},{"date":"2025-09-05","current":52.179399,"twenty":15.818034,"median":29.83907,"eighty":45.065741,"marketCap":48057469940.35},{"date":"2025-09-12","current":51.255365,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47683369897.6},{"date":"2025-09-19","current":51.084248,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47282912126.15},{"date":"2025-09-26","current":50.627935,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46290416349.68},{"date":"2025-10-03","current":48.574526,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45123442627.46},{"date":"2025-10-10","current":48.163844,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43057554125.18},{"date":"2025-10-17","current":47.810202,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43420086875.26},{"date":"2025-10-24","current":49.008023,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43939898848.11},{"date":"2025-10-31","current":196.128812,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":42096877735.37},{"date":"2025-11-07","current":199.628241,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":43122516182.74},{"date":"2025-11-14","current":212.188582,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45471927947.27},{"date":"2025-11-21","current":211.902035,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":44500274886.11},{"date":"2025-11-28","current":215.197333,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45545101317.81},{"date":"2025-12-05","current":210.61257,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45011991214.34},{"date":"2025-12-12","current":212.427372,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45254225772.44},{"date":"2025-12-19","current":219.877613,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":46788038894.3},{"date":"2025-12-26","current":232.581228,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":49307900125.5},{"date":"2026-01-02","current":230.9097,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":48729268900.59},{"date":"2026-01-09","current":242.610705,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":51132650268.4},{"date":"2026-01-16","current":242.276399,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":50569808771.94},{"date":"2026-01-23","current":244.329994,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":51041613744.96},{"date":"2026-01-30","current":73.324517,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":54139767928.12},{"date":"2026-02-06","current":77.171186,"twenty":15.819699,"median":29.842804,"eighty":45.118598,"marketCap":55518181293.68},{"date":"2026-02-13","current":78.528012,"twenty":15.819699,"median":29.842804,"eighty":45.203169,"marketCap":58174278066.56},{"date":"2026-02-18","current":81.25565,"twenty":15.819699,"median":29.842804,"eighty":45.284184,"marketCap":59441180233.72}],"updateTime":1771495526699},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TAK\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612488284","title":"Takeda Reports 47% of Patients Met Primary Endpoint in Entyvio Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2612488284","media":"Dow Jones","labels":["dataReport"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/2612488284?lang=en_us&edition=fundamental","pubTime":"2026-02-20 01:43","pubTimestamp":1771522980,"startTime":"0","endTime":"0","summary":"Takeda said data from a Phase 3 trial showed its Entyvio treatment provides the  possibility of achieving clinical remission in pediatric patients with a form of gastrointestinal tract disease.The pharmaceutical company said Thursday that about 47% of patients between the ages of two and 17 reached the primary endpoint of clinical remission after 54 weeks. About 35% reached clinical remission after 14 weeks, the secondary endpoint of the study.Entyvio, the brand name for vedolizumab, is designed to treat moderate to severe active ulcerative colitis, a disease involving chronic inflammation of the GI tract.\"We observed clinically meaningful improvements with vedolizumab in an especially difficult-to-treat patient population--children and adolescents who had failed on the current standard of care, including conventional therapies and/or tumor necrosis factor  antagonists,\" MNGI Digestive Health gastroenterologist Ramalingam Arumugam, one of the investigators on the study, said.Takeda sai","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Takeda Reports 47% of Patients Met Primary Endpoint in Entyvio Trial","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2612284354","title":"Takeda announces data from Phase 3 KEPLER trial of ENTYVIO","url":"https://stock-news.laohu8.com/highlight/detail?id=2612284354","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612284354?lang=en_us&edition=fundamental","pubTime":"2026-02-20 01:11","pubTimestamp":1771521100,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced data from the pivotal Phase 3 KEPLER trial, which demonstrated that ENTYVIO can offer the possibility of clinical remission ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-announces-data-from-phase-3-kepler-trial-of-entyvio-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-announces-data-from-phase-3-kepler-trial-of-entyvio-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2612159447","title":"Takeda’s New Stroke Trial Adds Long-Term Optionality to TAK’s Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2612159447","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612159447?lang=en_us&edition=fundamental","pubTime":"2026-02-19 00:31","pubTimestamp":1771432296,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is launching a Phase 2 trial titled “A Phase...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-new-stroke-trial-adds-long-term-optionality-to-taks-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-new-stroke-trial-adds-long-term-optionality-to-taks-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2612471114","title":"Takeda’s HyQvia Study Tracks Real-World Use in Multiple Myeloma, Offering Gradual Upside for TAK Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2612471114","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612471114?lang=en_us&edition=fundamental","pubTime":"2026-02-19 00:31","pubTimestamp":1771432281,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda is running a prospective, observational study call...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-hyqvia-study-tracks-real-world-use-in-multiple-myeloma-offering-gradual-upside-for-tak-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-hyqvia-study-tracks-real-world-use-in-multiple-myeloma-offering-gradual-upside-for-tak-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","ISBC","BK4007","BK4211"],"gpt_icon":0},{"id":"2612471634","title":"Takeda Targets Better Hereditary Angioedema Diagnosis With New AHAE Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2612471634","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612471634?lang=en_us&edition=fundamental","pubTime":"2026-02-19 00:31","pubTimestamp":1771432268,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is backing a new diagnostic study for heredi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-targets-better-hereditary-angioedema-diagnosis-with-new-ahae-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-targets-better-hereditary-angioedema-diagnosis-with-new-ahae-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2612549442","title":"Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2612549442","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612549442?lang=en_us&edition=fundamental","pubTime":"2026-02-18 23:45","pubTimestamp":1771429534,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were higher Wednesday morning, up 0.6% to 2,985.58 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by e-commerce company PDD  and Takeda Pharmaceutical , which advanced 2.1% and 2%, respectively.They were followed by financial technology companies LexinFintech  and FinVolution , which climbed 1.8% and 1.6%, respectively.The decliners from North Asia were led by sports and social business company Leifras  and Internet and data center service provider VNET , which fell 12% and 9.6%, respectively.They were followed by game-related entertainment and services provider Huya , which shed 2.4%.From South Asia, the gainers were led by IT service management company Trident Digital Tech  and tech conglomerate Sea , which gained 4.7% and 3.1%, respectively.The decliners from South Asia were led by telecom Telkom Indonesia , which decreased 0.7%.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4554","LU1880383366.USD","LU1961090484.USD","LU0175139822.USD","LU0329678337.USD","BK7093","TDTH","BK4122","LU0359201885.HKD","BK4558","TAK","BK4526","LU1303224171.USD","LU2045819591.USD","LU0049112450.USD","BK4566","LU1251922891.USD","LU0737861269.HKD","LU1023057109.AUD","SG9999002604.SGD","LU0588546209.SGD","LU1719994722.HKD","LU0329678170.USD","BK4548","LU1861220207.SGD","LU1064131342.USD","BK4551","LU2125910849.SGD","BK4513","LU0572940350.SGD","SGXZ58947870.SGD","LU0164865239.USD","SG9999002463.SGD","SG9999013460.SGD","BK4505","HK0000306685.HKD","LU0516422366.SGD","LU0516422952.EUR","LU1323998911.USD","SG9999014484.SGD","LU1242518931.SGD","LU1794554557.SGD","LU0289960550.SGD","LU0589944569.HKD","LU0979878070.USD","BK4134","LU2087589342.USD","LU1242518857.USD","LU2065169927.USD","LU1171460220.USD","LU1956131251.USD","LU0072462343.USD","LU1770034418.SGD","LU0251143029.SGD","LU0516422440.USD","LU0348805143.USD","FINV","LU0821914370.USD","LU2065171402.SGD","BK4501","LU0823413660.USD","BK4204","LU0231483743.USD","BK4581","LU0502904849.HKD","LU1861217088.USD","SG9999005177.SGD","LU0259732245.USD","LU1769817179.HKD","LU0359202008.SGD","BK4007","LU0541501648.USD","BK4509","SG9999014674.SGD","BK4553","LU0871576103.HKD","SG9999002414.USD","LU0823397285.USD","LU1048588211.SGD","LU1868837565.USD","LU2238330802.EUR","BK4107","LU0561508036.HKD","LU0315179316.USD","LU0348788117.USD","LU0370786039.SGD","LU0456846285.SGD","HK0000320223.HKD","LU0441851309.USD","BK4504","SG9999004360.SGD","LU0737861772.HKD","LU2360107671.USD","LU2543165471.USD","LU2177674079.SGD","VNET","LU0572944931.SGD","SG9999002679.SGD","SG9999001135.SGD","LU2065171311.SGD","PDD","LU1769817096.USD","LU0345775950.USD","LU1770036033.HKD","HK0000320264.USD","LU0143863198.USD","BK4585","LU0516423091.SGD","LU1981816686.USD","IE00B3M56506.USD","LU2125910500.SGD","LU0417516902.SGD","LU2152927971.USD","SG9999014492.USD","LU0047713382.USD","BK4220","LU0532188223.SGD","LU0594300179.USD","LU0605514214.HKD","LU0348825331.USD","LU1808992512.USD","LU1839390173.USD","HK0000306701.USD","LU0052750758.USD","LU0499858438.USD","LU0531971595.HKD","LU0235996351.USD","BK4535","LU0264606111.USD","LU0823426480.USD","LU0823397103.USD","LU2264538146.SGD","LU0261945553.USD","LU0210637038.USD","SG9999013478.USD","LU0327786744.USD","LU0345776255.USD","BK4115","LU1988902786.USD","BK4085","LU0143863784.USD","BK4531","IE0034224299.USD","LU0048573645.USD","LU0051755006.USD","LFS","LU0210526637.USD","LU0348827113.USD","BK4166","LU2008162690.USD","BK4116","BK4607","LU0117841782.USD","LU0328353924.USD","IE0001KFT4U8.USD","LU0823039010.USD","IE00B29SXG58.USD","LU0456827905.SGD","LU0878005551.USD","SG9999002562.SGD","BK4503","LU0541502299.USD","LU0633140560.USD","SG9999013486.USD","IE00BD6J9T35.USD","LU1048596156.SGD","LU1880383440.USD","SG9999002406.SGD","LU2399975544.HKD","SG9999002620.SGD","SG9999006266.SGD","LU0455707207.USD","LU0516423174.USD","LU0708995583.HKD","LU0823413587.USD","LU2065170008.USD","LU0320764599.SGD","SE","LU0594300419.USD","IE0031814969.USD","LU0307460666.USD","LU0823038988.USD","LU0633140727.USD","LU1046422090.SGD","LU2039709279.SGD","LU1868838027.USD","LU0572939691.SGD","LU2242644610.SGD","SG9999002828.SGD","LU1235295612.USD","TLK","HUYA","BK4588","LU0650527681.SGD","IE00B0JY6N72.USD","LU2257852520.SGD","LU0683595622.HKD","LU2211817866.USD","IE00BGV7N243.SGD","LU0048580855.USD","LU0039217434.USD","LU1720050803.USD","LU0359201612.USD","LU1868837722.USD","LX","BK4579","LU0499858602.USD","LU0823426308.USD","BK4117","LU0140636845.USD"],"gpt_icon":1},{"id":"2611613521","title":"Takeda Advances Phase 3 Teen Depression Trial, Underscoring Its Neuroscience Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2611613521","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611613521?lang=en_us&edition=fundamental","pubTime":"2026-02-14 00:31","pubTimestamp":1771000303,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is running a Phase 3 study called “A Randomi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-advances-phase-3-teen-depression-trial-underscoring-its-neuroscience-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-advances-phase-3-teen-depression-trial-underscoring-its-neuroscience-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2611341161","title":"Takeda Pushes Pediatric Psoriasis Drug TAK-279 Forward With New Phase 3 Trial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2611341161","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611341161?lang=en_us&edition=fundamental","pubTime":"2026-02-14 00:31","pubTimestamp":1771000277,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda is running a phase 3 trial to test its drug zasoci...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-pushes-pediatric-psoriasis-drug-tak-279-forward-with-new-phase-3-trial-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-pushes-pediatric-psoriasis-drug-tak-279-forward-with-new-phase-3-trial-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2610897952","title":"Takeda Advances Oral Crohn’s Disease Drug TAK-279 With Active Mid-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2610897952","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610897952?lang=en_us&edition=fundamental","pubTime":"2026-02-12 00:31","pubTimestamp":1770827515,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is running a mid-stage study called “A Phase...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-advances-oral-crohns-disease-drug-tak-279-with-active-mid-stage-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-advances-oral-crohns-disease-drug-tak-279-with-active-mid-stage-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK","SSI"],"gpt_icon":0},{"id":"2610646126","title":"Takeda granted Priority Review for oveporexton by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2610646126","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610646126?lang=en_us&edition=fundamental","pubTime":"2026-02-10 18:25","pubTimestamp":1770719129,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced that the FDA accepted its new drug application and granted Priority Review for oveporexton for the treatment of narcolepsy t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-granted-priority-review-for-oveporexton-by-fda-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-granted-priority-review-for-oveporexton-by-fda-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2610065027","title":"Takeda Taps AI Startup Iambic In $1.7 Billion+ Deal To Speed Up Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2610065027","media":"Benzinga","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610065027?lang=en_us&edition=fundamental","pubTime":"2026-02-10 01:59","pubTimestamp":1770659940,"startTime":"0","endTime":"0","summary":"AI startup Iambic on Monday announced a multi-year technology and discovery collaboration agreement with Takeda Pharmaceutical Company Limited .The Japanese drug maker will use Iambic's AI drug discovery models to advance a select set of high-priority small molecule programs, initially in Takeda's oncology, gastrointestinal, and inflammation therapeutic areas.Through the agreement, Takeda will also gain access to NeuralPLexer, Iambic's model for predicting protein-ligand complexes.Based in San Diego and founded in 2020, Iambic is a clinical-stage life-science and technology company developing novel medicines using its AI-driven discovery and development platform.\"Our collaboration with Takeda is a powerful opportunity to apply our AI-driven discovery and development platform, and we are excited to partner with their team to quickly advance new and better drug candidates,\" said Tom Miller, Co-Founder and CEO of Iambic.\"Iambic's small molecule platform aligns with this ambition and offer","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/09/Takeda-Pharma-Photo-by-Veroniksha-via-Sh.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/09/Takeda-Pharma-Photo-by-Veroniksha-via-Sh.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/26/02/50489158/takeda-taps-ai-startup-iambic-in-1-7-billion-deal-to-speed-up-drug-discovery","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/02/50489158/takeda-taps-ai-startup-iambic-in-1-7-billion-deal-to-speed-up-drug-discovery","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4023","BK4528","BK4585","BK4543","BK4551","BK4587","BK4588","TAK","AI","BK4007"],"gpt_icon":0},{"id":"1177284181","title":"Takeda Pharmaceutical Invests $1.7 Billion in Iambic to Expand AI-Powered Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=1177284181","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177284181?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:30","pubTimestamp":1770643833,"startTime":"0","endTime":"0","summary":"Private company Iambic announced on Monday that it has entered into a multi-year collaboration with Japan's Takeda Pharmaceutical Co Ltd, valued at over $1.7 billion. The partnership will leverage...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK","161631","BK4007"],"gpt_icon":0},{"id":"2609590057","title":"Takeda’s TAK-188 Trial: Early Immunotherapy Bet in Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2609590057","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609590057?lang=en_us&edition=fundamental","pubTime":"2026-02-07 00:32","pubTimestamp":1770395525,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Study OverviewThis Takeda-sponsored trial, officially tit...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-tak-188-trial-early-immunotherapy-bet-in-advanced-solid-tumors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-tak-188-trial-early-immunotherapy-bet-in-advanced-solid-tumors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AEIS","BK4157","IE00B7SZL793.SGD","LU0757428866.USD","IE00B66KJ199.SGD","IE0031619046.USD","TAK","IE00B19Z4B17.USD","LU1815336091.USD","BK4007"],"gpt_icon":0},{"id":"2609590084","title":"Takeda Advances TAK-360 Sleep Disorder Trial, Signaling Growing Ambition in Orexin-Based Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2609590084","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609590084?lang=en_us&edition=fundamental","pubTime":"2026-02-07 00:31","pubTimestamp":1770395514,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Study OverviewThis Phase 2 study, officially titled “A Do...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-advances-tak-360-sleep-disorder-trial-signaling-growing-ambition-in-orexin-based-therapies?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-advances-tak-360-sleep-disorder-trial-signaling-growing-ambition-in-orexin-based-therapies?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2607284040","title":"Takeda Advances TAK-279 in Ulcerative Colitis: What Investors Should Watch Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2607284040","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607284040?lang=en_us&edition=fundamental","pubTime":"2026-01-31 00:33","pubTimestamp":1769790786,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Study Overview: Takeda is running a Phase 2 study called ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-advances-tak-279-in-ulcerative-colitis-what-investors-should-watch-next?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-advances-tak-279-in-ulcerative-colitis-what-investors-should-watch-next?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","TAK","ISBC","BK4007"],"gpt_icon":0},{"id":"2607303354","title":"Takeda Flags Vyvanse Hit, Lifts 2025 Profit Guidance On Cost Control","url":"https://stock-news.laohu8.com/highlight/detail?id=2607303354","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607303354?lang=en_us&edition=fundamental","pubTime":"2026-01-29 22:11","pubTimestamp":1769695893,"startTime":"0","endTime":"0","summary":"Takeda missed Q3 earnings estimates as Vyvanse generic pressure weighed on sales, but raised its 2025 profit forecast on cost discipline and favorable currency moves.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/01/50229026/takeda-flags-vyvanse-hit-lifts-2025-profit-guidance-on-cost-control","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0661504455.SGD","BK4007","LU2500361329.USD","TAK","ADHD","LU0545039389.USD","BK4588","BK4585","LU1894683264.USD","CMS","LU0738911758.USD","LU1894683348.USD","LU0949170772.SGD","LU0553294199.USD","LU2637428348.USD","BK4208","LU1003077747.HKD","LU2346227817.USD"],"gpt_icon":0},{"id":"2607083625","title":"Takeda raises FY25 core EPS view to 486 yen from 479 yen","url":"https://stock-news.laohu8.com/highlight/detail?id=2607083625","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607083625?lang=en_us&edition=fundamental","pubTime":"2026-01-29 18:35","pubTimestamp":1769682930,"startTime":"0","endTime":"0","summary":"Raises FY25 revenue view to 4.53B yen from 4.5B yen. The company said, “Takeda (TAK) has updated its full year Management Guidance for Revenue prim...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-raises-fy25-core-eps-view-to-486-yen-from-479-yen-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-raises-fy25-core-eps-view-to-486-yen-from-479-yen-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2607836570","title":"Takeda reports Q3 core EPS 428 yen vs. 443 yen last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2607836570","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607836570?lang=en_us&edition=fundamental","pubTime":"2026-01-29 18:30","pubTimestamp":1769682636,"startTime":"0","endTime":"0","summary":"Reports Q3 revenue 3.41B yen vs. 3.53B yen last year. Takeda (TAK) chief financial officer, Milano Furuta, commented: “While we manage the impact o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-reports-q3-core-eps-428-yen-vs-443-yen-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-reports-q3-core-eps-428-yen-vs-443-yen-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2607708071","title":"Takeda Pharmaceutical Q3 Adj. EPS $0.47 Misses $0.55 Estimate, Sales $7.600B Miss $8.530B Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2607708071","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607708071?lang=en_us&edition=fundamental","pubTime":"2026-01-29 14:58","pubTimestamp":1769669888,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings of $0.47 per share which missed the analyst consensus estimate of $0.55 by 13.64 percent. This is a 7.95 percent increase over earnings of $0.44 per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/01/50216195/takeda-pharmaceutical-q3-adj-eps-0-47-misses-0-55-estimate-sales-7-600b-miss-8-530b-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2607086647","title":"Press Release: Takeda Reports Third-Quarter FY2025 Results: Updates Full Year Outlook to Reflect VYVANSE(R) Generics Impact, OPEX Discipline and FX Tailwind; Progressing Toward Three Transformative Launches Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2607086647","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607086647?lang=en_us&edition=fundamental","pubTime":"2026-01-29 14:37","pubTimestamp":1769668620,"startTime":"0","endTime":"0","summary":"--  Year-to-Date Revenue Declined by 2.8% at Constant Exchange Rate ,--  Core Operating Profit Declined by 3.4% at both CER and AER Year to Date. --  Reported Operating Profit Increased by 1.2% at AER Year to Date, Lower. Takeda is positioned for long-term growth and has multiple late-stage programs with multibillion-dollar peak revenue potential. Following the positive readouts from Phase 3 studies in 2025, the company has submitted New Drug Applications  for oveporexton and rusfertide and is on track to file an NDA for zasocitinib. Each of these programs, which Takeda expects to launch within the next 18 months, has the potential to redefine standards of care, transform patient lives and contribute to Takeda's new growth trajectory.\"FY2025 remains a truly pivotal year for Takeda as we are in a phase of preparing for significant new product launches. Looking ahead, with multiple innovative launches and a robust late-stage pipeline, Takeda is positioned to bring life-transforming medic","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","R","BK4007","BK4232","AER","OPEX","LU0109981661.USD","LU0211331839.USD","TAK","BK4104","LU1098665638.USD","BK4572"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":66,"code":"91000000","status":"200"}]}}